Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7153
+0.0201 (2.89%)
At close: May 29, 2026, 4:00 PM EDT
0.7153
0.00 (0.00%)
After-hours: May 29, 2026, 4:00 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $23.94 million as of May 29, 2026. Its market cap has increased by 359.98% in one year.
Market Cap
23.94M
Enterprise Value
-27.17M
1-Year Change
359.98%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $23.94M, a decrease of -63.33%. That is a compound annual growth rate of -19.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 23.23M | -22.02% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 25.26M |
| Cellectar Biosciences | 25.09M |
| Vistagen Therapeutics | 24.73M |
| Marker Therapeutics | 24.02M |
| Werewolf Therapeutics | 23.81M |
| Longeveron | 23.28M |
| Traws Pharma | 23.18M |
| Sensei Biotherapeutics | 22.69M |